Laurent Humeau - Feb 26, 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Scientific Officer
Signature
/s/ Laurent Humeau
Stock symbol
INO
Transactions as of
Feb 26, 2023
Transactions value $
-$35,759
Form type
4
Date filed
2/28/2023, 04:43 PM
Previous filing
Mar 14, 2022
Next filing
Mar 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +22.5K +16.74% 157K Feb 26, 2023 Direct F1
transaction INO Common Stock Tax liability -$11.6K -9.07K -5.77% $1.28 148K Feb 26, 2023 Direct F2
transaction INO Common Stock Options Exercise +46.3K +31.23% 194K Feb 26, 2023 Direct F3
transaction INO Common Stock Tax liability -$24.2K -18.9K -9.7% $1.28 176K Feb 26, 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -22.5K -50% $0.00 22.5K Feb 26, 2023 Common Stock 22.5K Direct F1
transaction INO Restricted Stock Unit Options Exercise $0 -46.3K -33.33% $0.00 92.5K Feb 26, 2023 Common Stock 46.3K Direct F3
transaction INO Common Stock Option Award $0 +225K $0.00 225K Feb 27, 2023 Common Stock 225K $1.24 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.
F5 The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026.